PL1989217T3 - 11-fosforowe pochodne steroidowe użyteczne jako modulatory receptora progesteronu - Google Patents

11-fosforowe pochodne steroidowe użyteczne jako modulatory receptora progesteronu

Info

Publication number
PL1989217T3
PL1989217T3 PL07757084T PL07757084T PL1989217T3 PL 1989217 T3 PL1989217 T3 PL 1989217T3 PL 07757084 T PL07757084 T PL 07757084T PL 07757084 T PL07757084 T PL 07757084T PL 1989217 T3 PL1989217 T3 PL 1989217T3
Authority
PL
Poland
Prior art keywords
receptor modulators
progesterone receptor
derivatives useful
steroid derivatives
phosphorous
Prior art date
Application number
PL07757084T
Other languages
English (en)
Other versions
PL1989217T4 (pl
Inventor
Weiqin Jiang
Zhihua Sui
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PL1989217T3 publication Critical patent/PL1989217T3/pl
Publication of PL1989217T4 publication Critical patent/PL1989217T4/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J51/00—Normal steroids with unmodified cyclopenta(a)hydrophenanthrene skeleton not provided for in groups C07J1/00 - C07J43/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/36—Antigestagens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
PL07757084T 2006-02-17 2007-02-16 11-fosforowe pochodne steroidowe użyteczne jako modulatory receptora progesteronu PL1989217T4 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US77473506P 2006-02-17 2006-02-17
PCT/US2007/062272 WO2007098381A2 (en) 2006-02-17 2007-02-16 11-phosphorous steroid derivatives useful as progesterone receptor modulators
EP07757084A EP1989217B1 (en) 2006-02-17 2007-02-16 11-phosphorous steroid derivatives useful as progesterone receptor modulators

Publications (2)

Publication Number Publication Date
PL1989217T3 true PL1989217T3 (pl) 2012-11-30
PL1989217T4 PL1989217T4 (pl) 2013-02-28

Family

ID=38438062

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07757084T PL1989217T4 (pl) 2006-02-17 2007-02-16 11-fosforowe pochodne steroidowe użyteczne jako modulatory receptora progesteronu

Country Status (13)

Country Link
US (1) US7678781B2 (pl)
EP (1) EP1989217B1 (pl)
JP (1) JP5230449B2 (pl)
CN (1) CN101415720B (pl)
AU (1) AU2007217094A1 (pl)
CA (1) CA2642829A1 (pl)
CY (1) CY1113146T1 (pl)
DK (1) DK1989217T5 (pl)
ES (1) ES2388752T3 (pl)
PL (1) PL1989217T4 (pl)
PT (1) PT1989217E (pl)
SI (1) SI1989217T1 (pl)
WO (1) WO2007098381A2 (pl)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008109719A2 (en) * 2007-03-07 2008-09-12 Janssen Pharmaceutica N.V. Steroids derivatives as selective progesterone receptor modulators
CN101926806A (zh) * 2009-06-24 2010-12-29 天津金耀集团有限公司 一种17磷类雌甾化合物在制备紧急避孕药物中的应用
CN102617691B (zh) * 2012-01-18 2014-05-14 上海新华联制药有限公司 一种改进的米非司酮中间体制备方法
WO2014060888A1 (en) 2012-10-18 2014-04-24 Lupin Limited Novel process and intermediate for preparation of ulipristal
RU2017112748A (ru) 2014-11-17 2018-12-19 Арно Терапьютикс, Инк. Композиции онапристона пролонгированного действия и способы
CA2998924A1 (en) * 2015-09-25 2017-03-30 Context Biopharma Inc. Methods of making onapristone intermediates
CA3008422A1 (en) 2015-12-15 2017-06-22 Context Biopharma Inc. Amorphous onapristone compositions and methods of making the same
US20180148471A1 (en) 2016-11-30 2018-05-31 Arno Therapeutics, Inc. Methods for onapristone synthesis dehydration and deprotection
WO2023000135A1 (en) * 2021-07-19 2023-01-26 Context Biopharma Inc. Processes of making onapristone and intermediates thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9003939D0 (en) * 1990-02-21 1990-04-18 Imperial College Sulphatase inhibitors
ZA929315B (en) 1991-12-20 1993-05-24 Akzo Nv 17-spirofuran-3'-ylidene steroids.
CA2100514C (en) 1992-07-29 2005-03-29 Johannes A. M. Hamersma 17-spiromethylene steroids
JPH0995496A (ja) * 1995-09-28 1997-04-08 Kaken Pharmaceut Co Ltd ウルソデオキシコール酸誘導体
JP4553586B2 (ja) * 2001-10-18 2010-09-29 ステリックス リミテッド ステロイドスルファターゼを阻害するための、ステロイド化合物
ATE453660T1 (de) 2006-02-17 2010-01-15 Janssen Pharmaceutica Nv 17-phosphor-steroid-derivate als progesteron- rezeptormodulatoren

Also Published As

Publication number Publication date
ES2388752T3 (es) 2012-10-18
JP2009527489A (ja) 2009-07-30
PT1989217E (pt) 2012-08-30
SI1989217T1 (sl) 2012-09-28
HK1131396A1 (en) 2010-01-22
DK1989217T5 (da) 2013-01-14
CY1113146T1 (el) 2016-04-13
CN101415720A (zh) 2009-04-22
US20070232570A1 (en) 2007-10-04
JP5230449B2 (ja) 2013-07-10
EP1989217A2 (en) 2008-11-12
EP1989217B1 (en) 2012-06-27
WO2007098381A3 (en) 2008-01-03
DK1989217T3 (da) 2012-10-08
US7678781B2 (en) 2010-03-16
CN101415720B (zh) 2011-10-05
HK1125652A1 (en) 2009-08-14
CA2642829A1 (en) 2007-08-30
AU2007217094A1 (en) 2007-08-30
PL1989217T4 (pl) 2013-02-28
WO2007098381A2 (en) 2007-08-30

Similar Documents

Publication Publication Date Title
ZA200904150B (en) Progesterone receptor antagonists
PL2176220T3 (pl) Pochodne pirolidyn-2-onu jako modulatory receptora androgenowego
IL198410A0 (en) Tetrahydrocyclopenta [b] indole compounds as androgen receptor modulators
PL1989217T3 (pl) 11-fosforowe pochodne steroidowe użyteczne jako modulatory receptora progesteronu
IL191710A0 (en) Glucocorticoid receptor modulators as antiinflammatory agents
SI2564900T1 (sl) Steroidi C-19 za terapevtske uporabe
IL184374A0 (en) Non steroidal glucocorticoid receptor modulators
ZA200800689B (en) Benzofuranone derivatives as nonsteroidal progesterone receptor modulators
IL188314A0 (en) Cyanopyrrole-sulfonamide progesterone receptor modulators and uses thereof
DK2066677T3 (da) Pyridooxazepinprogesteronreceptormodulatorer
ZA200806237B (en) Cannibinoid receptor modulators
SI1991559T1 (sl) Oksa-steroidni derivati kot selektivni modulatorji progesteronskega receptorja
HK1125945A (en) 17-phosphorous steroid derivatives useful as progesterone receptor modulators
ZA200907546B (en) New progesterone receptor modulators
HK1139393A (en) Steroids derivatives as selective progesterone receptor modulators
HK1141515A (en) New progesterone receptor modulators
IL178010A0 (en) Progesterone receptor modulators
HK1122811A (en) Cannibinoid receptor modulators